Claims for harm linked to Dupixent in Arizona

Arizona's rapidly growing population and large elderly demographic drive substantial Dupixent prescribing volume, particularly in the Phoenix and Tucson metropolitan areas where major dermatology and allergy practices serve the state's 7.4 million residents. The Mayo Clinic Arizona campus in Scottsdale provides world-class cutaneous lymphoma diagnostic evaluation, and Banner Health's extensive network covers much of the state's dermatological care. Arizona's product liability framework is plaintiff-friendly: the state follows strict liability under the Restatement (Second) of Torts § 402A, applies pure comparative fault (meaning plaintiff recovery is reduced but never barred by comparative negligence), and imposes no statutory caps on compensatory or punitive damages. The District of Arizona in Phoenix has managed complex pharmaceutical litigation efficiently, and Arizona's growing population of transplants from other states creates a diverse jury pool with limited ties to pharmaceutical industry defendants.

For the overall process and updates, read the Claims for harm linked to Dupixent overview. This page covers the local information available for Arizona.